David Parrot

Chief Financial Officer at Scribe Therapeutics · 2 reported transactions in 1 company · latest trade Jul 23, 2026

Their record

No purchases old enough to measure yet.


Scribe TherapeuticsSCTX	Bought $20K · 1,333 shares	Jul 23, 2026	S&P 500 +4.1%thru Oct 29
Scribe TherapeuticsSCTX	Bought $20K · 1,333 shares	Jul 23, 2026	S&P 500 +4.1%thru Oct 29

Jul 23, 2026 · SCTX

$20K

S&P 500 +4.1%thru Oct 29

Jul 23, 2026 · SCTX

$20K

S&P 500 +4.1%thru Oct 29

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Financial Officer at Scribe Therapeutics · 2 reported transactions in 1 company · latest trade Jul 23, 2026

No purchases old enough to measure yet.


Scribe TherapeuticsSCTX	Bought $20K · 1,333 shares	Jul 23, 2026	S&P 500 +4.1%thru Oct 29
Scribe TherapeuticsSCTX	Bought $20K · 1,333 shares	Jul 23, 2026	S&P 500 +4.1%thru Oct 29

Jul 23, 2026 · SCTX

$20K

S&P 500 +4.1%thru Oct 29

Jul 23, 2026 · SCTX

$20K

S&P 500 +4.1%thru Oct 29

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.